טוען...
The efficacy of betulinic acid in triple-negative breast cancer
PURPOSE: The treatment of triple-negative breast cancer remains a daunting challenge with the standard-of-care treatments eventually failing due to acquired drug resistance, toxic side effects and the presence of a deregulated immune response. New treatments for overcoming these drawbacks include th...
שמור ב:
| הוצא לאור ב: | SAGE Open Med |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publications
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4607226/ https://ncbi.nlm.nih.gov/pubmed/26770742 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050312114551974 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|